Cepheid Delivers Xpert® Hemorrhagic Fever Panel Tests to Africa to Address Diagnostic Gaps in Ebola Bundibugyo OutbreakCepheid, a Danaher company, today announced it has donated an initial shipment of Xpert® Hemorrhagic Fever panel tests to support the diagnostic response to the Ebola Bundibugyo (BDBV) outbreak in the Democratic Republic of the Congo (DRC) and Uganda. The World Health Organization (WHO) declared the outbreak a Public Health Emergency of International Concern on May 17, 2026.1
Fleming Initiative and Cepheid Launch Landmark Study of Rapid Testing for Drug-Resistant Infections
The Fleming Initiative, a partnership established by Imperial College London and Imperial College Healthcare NHS Trust to combat antimicrobial resistance (AMR), and Cepheid, a Danaher company, today announced the launch of TRACE-CPE, a two-and-a-half-year research study to improve testing for AMR, one of the greatest global health challenges.
